Vimarsana
Biggest News Aggregation in the World

Page 3 - Contract Development Manufacturing News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Contract Development Manufacturing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Contract Development Manufacturing Today - Breaking & Trending Today

CordenPharma Completes Acquisition of Three Manufacturing Facilities from Vifor Pharma - Vimarsana News

CordenPharma Completes Acquisition of Three Manufacturing Facilities from Vifor Pharma

/PRNewswire/ -- CordenPharma, a leading, full-service Contract Development & Manufacturing Organization (CDMO) supplying APIs, Excipients, Drug Products, and...

CordenPharma Completes Acquisition of Three Manufacturing Facilities from Vifor Pharma - Vimarsana News

CordenPharma Completes Acquisition of Three Manufacturing Facilities from Vifor Pharma

/PRNewswire/ -- CordenPharma, a leading, full-service Contract Development & Manufacturing Organization (CDMO) supplying APIs, Excipients, Drug Products, and...

Vifor Pharma drives transformation with divestment of non-core finished drug manufacturing to CordenPharma - Vimarsana News

Vifor Pharma drives transformation with divestment of non-core finished drug manufacturing to CordenPharma

Press release content from Business Wire. The AP news staff was not involved in its creation.

Source: apnews.com
Vifor Pharma Group: Vifor Pharma drives transformation with divestment of non-core finished drug manufacturing to CordenPharma - Vimarsana News

Vifor Pharma Group: Vifor Pharma drives transformation with divestment of non-core finished drug manufacturing to CordenPharma

Focus on expansion in nephrology, and to maximize opportunities on the iron portfolio Vifor Pharma to divest non-core assets on finished drug product facilities to CordenPharma, reducing organizational

XPhyto Therapeutics Corp.: XPhyto Announces Drug Formulation Strategy and 2021 Milestones Innovation to Impact - Vimarsana News

XPhyto Therapeutics Corp.: XPhyto Announces Drug Formulation Strategy and 2021 Milestones Innovation to Impact

XPhyto Therapeutics Corp.: XPhyto Announces Drug Formulation Strategy and 2021 Milestones Innovation to Impact Four clinical studies in neurological indications in 2021 Development of oral biosensor and contract development & manufacturing Psychedelic transdermal and sublingual drug formulation development VANCOUVER, BC / ACCESSWIRE / January 28, 2021 / XPhyto Therapeutics Corp. ( XPhyto" or the " Company") is pleased to announce its drug formulation and delivery business strategy and milestones for 2021. As a bioscience accelerator at the leading-edge of the life science industry, XPhyto tar...